Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puja R Mehta

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Biorxiv : the Preprint Server for Biology|July 9, 2024
Loss of TDP-43 induces synaptic dysfunction that is rescued by <i>UNC13A</i> splice-switching ASOsMatthew J Keuss, Peter Harley, Eugeni Ryadnov, et al.
Annals of Neurology|December 15, 2018
Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasiaKatherine Schon, Nienke J H van Os, Nicholas Oscroft, et al.
Journal of Neurochemistry|February 9, 2022
Amyloid processing in COVID-19-associated neurological syndromesOliver J Ziff, Nicholas J Ashton, Puja R Mehta, et al.
Eclinicalmedicine|January 13, 2023
The role of the electroencephalogram (EEG) in determining the aetiology of catatonia: a systematic review and meta-analysis of diagnostic test accuracyParis Hosseini, Rebecca Whincup, Karrish Devan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 10, 2019
Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trialJulian Gold, Dominic B Rowe, Matthew C Kiernan, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
U7 small nuclear RNA splice-switching therapeutics for STMN2 and UNC13A in Amyotrophic Lateral SclerosisPuja R Mehta, Tomas Solomon, Sarah Pickles, et al.
Biorxiv : the Preprint Server for Biology|February 5, 2024
TDP-43 loss induces extensive cryptic polyadenylation in ALS/FTDSam Bryce-Smith, Anna-Leigh Brown, Puja R Mehta, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Creation of de novo cryptic splicing for ALS/FTD precision medicineOscar G Wilkins, Max Z Y J Chien, Josette J Wlaschin, et al.
Science (New York, N.Y.)|October 3, 2024
Creation of de novo cryptic splicing for ALS and FTD precision medicineOscar G Wilkins, Max Z Y J Chien, Josette J Wlaschin, et al.
Nature Neuroscience|October 21, 2025
TDP-43 loss induces cryptic polyadenylation in ALS/FTDSam Bryce-Smith, Anna-Leigh Brown, Max Z Y J Chien, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|July 9, 2024
Loss of TDP-43 induces synaptic dysfunction that is rescued by <i>UNC13A</i> splice-switching ASOsMatthew J Keuss, Peter Harley, Eugeni Ryadnov, et al.
Annals of Neurology|December 15, 2018
Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasiaKatherine Schon, Nienke J H van Os, Nicholas Oscroft, et al.
Journal of Neurochemistry|February 9, 2022
Amyloid processing in COVID-19-associated neurological syndromesOliver J Ziff, Nicholas J Ashton, Puja R Mehta, et al.
Eclinicalmedicine|January 13, 2023
The role of the electroencephalogram (EEG) in determining the aetiology of catatonia: a systematic review and meta-analysis of diagnostic test accuracyParis Hosseini, Rebecca Whincup, Karrish Devan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 10, 2019
Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trialJulian Gold, Dominic B Rowe, Matthew C Kiernan, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
U7 small nuclear RNA splice-switching therapeutics for STMN2 and UNC13A in Amyotrophic Lateral SclerosisPuja R Mehta, Tomas Solomon, Sarah Pickles, et al.
Biorxiv : the Preprint Server for Biology|February 5, 2024
TDP-43 loss induces extensive cryptic polyadenylation in ALS/FTDSam Bryce-Smith, Anna-Leigh Brown, Puja R Mehta, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Creation of de novo cryptic splicing for ALS/FTD precision medicineOscar G Wilkins, Max Z Y J Chien, Josette J Wlaschin, et al.
Science (New York, N.Y.)|October 3, 2024
Creation of de novo cryptic splicing for ALS and FTD precision medicineOscar G Wilkins, Max Z Y J Chien, Josette J Wlaschin, et al.
Nature Neuroscience|October 21, 2025
TDP-43 loss induces cryptic polyadenylation in ALS/FTDSam Bryce-Smith, Anna-Leigh Brown, Max Z Y J Chien, et al.
Pageof 4